Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 4, 2024. (Total: 234082Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Coronary artery disease and CYP3A5[original query]
CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.
Pharmacogenomics 2008 Sep 9 (9): 1251-9.
Geisler Tobias, Schaeffeler Elke, Dippon Juergen, Winter Stefan, Buse Verena, Bischofs Christian, Zuern Christine, Moerike Klaus, Gawaz Meinrad, Schwab Matthi
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
JACC. Cardiovascular interventions 2013 Nov 6 (11): 11.
Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G
Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.
European journal of clinical pharmacology 2014 Jun 70 (6): 667-73.
Hokimoto Seiji, Chitose Tadasuke, Mizobe Michio, Akasaka Tomonori, Arima Yuichiro, Kaikita Koichi, Iwashita Satomi, Morita Kazunori, Miyazaki Hiroko, Oniki Kentaro, Matsui Kunihiko, Nakagawa Kazuko, Ogawa His
Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.
International journal of laboratory hematology 2015 Aug .
Arya V, Mahajan P, Saraf A, Mohanty A, Sawhney J P S, Bhargava
Comparison of the antiplatelet effect of clopidogrel benzene sulfonate and clopidogrel hydrogen sulfate in stable coronary heart disease.
Genetics and molecular research : GMR 2016 15 (2): .
Wang S H, Li X, Hou F L, Tian Y J, Liu Y H, Zheng S
SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.
European journal of clinical pharmacology 2017 Aug .
Liu Ju-E, Liu Xiao-Ying, Chen Sheng, Zhang Yan, Cai Li-Yun, Yang Min, Lai Wei-Hua, Ren Bin, Zhong Shi-Lo
Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease.
Archives of medical sciences. Atherosclerotic diseases 2017 2 e68-e75.
Shek Aleksandr B, Kurbanov Ravshanbek D, Abdullaeva Guzal J, Nagay Aleksandr V, Hoshimov Shavkat U, Nizamov Ulugbek I, Ziyaeva Adolat V, Alieva Rano
Population pharmacokinetics and pharmacodynamics of ticagrelor and AR-C124910XX in Chinese healthy male subjects.
European journal of clinical pharmacology 2018 Feb .
Liu Shuaibing, Xue Ling, Shi Xiangfen, Sun Zhiyong, Zhu Zhenfeng, Zhang Xiaojian, Tian X
Personalized rosuvastatin therapy in problem patients with partial statin intolerance.
Archives of medical sciences. Atherosclerotic diseases 2018 3 e83-e89.
Shek Aleksandr B, Kurbanov Ravshanbek D, Alieva Rano B, Abdullaeva Guzal J, Nagay Aleksandr V, Abdullaev Alisher A, Hoshimov Shavkat U, Nizamov Ulugbek
Drug-gene interactions in older patients with coronary artery disease.
BMC geriatrics 2024 10 24 (1): 881.
Shizhao Zhang, Chao Lv, Lisha Dong, Yangxun Wu, Tong Y
TOP